This Article Full Text Full Text (PDF) Supplemental Data Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibbons, C. Articles by Caron, K. M. Search for Related Content PubMed PubMed Citation Articles by Gibbons, C. Articles by Caron, K. M.

Receptor Activity-Modifying Proteins: RAMPing up Adrenomedullin Signaling

Department of Cell and Molecular Physiology (C.G., R.D., W.D., K.F.-S., K.M.C.), Genetics Department (R.D., W.D., K.M.C.), The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599

Address all correspondence and requests for reprints to: Kathleen M. Caron, Department of Cell and Molecular Physiology, CB # 7545, 6340B MBRB, 103 Mason Farm Road, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599. E-mail: Kathleen_caron{at}med.unc.edu.

Adrenomedullin (AM) is a 52-amino-acid multifunctional peptide that circulates in the plasma in the low picomolar range and can exert a multitude of biological effects through an autocrine/paracrine mode of action. The mechanism by which AM transduces its signal represents a novel and pharmacologically tractable paradigm in G protein-coupled receptor signaling. Since its discovery in 1993, the study of AM has emerged into a new field of research with nearly 1800 publications that rivals the renown of other common factors like angiopoetin (1015 publications) and ghrelin (1550 publications). Despite the tremendous strides made in recent years toward unveiling the biochemical and cellular functions of AM, we are still lagging in our understanding of the essential roles of AM in normal and disease physiology. As discussed in this current review, a concerted effort to combine information from clinical, genomic, biochemical, and genetic mouse model sources can provide a focused view to help define the physiological functions of AM. Specifically, we find that certain conditions, such as pregnancy, cardiovascular disease, and sepsis, are associated with robust and dynamic changes in the expression of AM and AM receptor proteins, which together represent an elegant mechanism for altering the physiological responsiveness or function of AM. Thus, the modulation of AM signaling may be further exploited for therapeutic strategies in the management and treatment of human disease.

This article has been cited by other articles:

				M. Li, Y. Wu, and K. M. Caron Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice Biol Reprod, December 1, 2008; 79(6): 1169 - 1175. [Abstract] [Full Text] [PDF]

				F. Harel, Y. Fu, Q. T. Nguyen, M. Letourneau, L. P. Perrault, A. Caron, A. Fournier, and J. Dupuis Use of Adrenomedullin Derivatives for Molecular Imaging of Pulmonary Circulation J. Nucl. Med., November 1, 2008; 49(11): 1869 - 1874. [Abstract] [Full Text] [PDF]

				K. Caron, J. Hagaman, T. Nishikimi, H.-S. Kim, and O. Smithies Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males PNAS, February 27, 2007; 104(9): 3420 - 3425. [Abstract] [Full Text] [PDF]